Latest oppositions filed by Accord Healthcare

This table presents recent patent oppositions filed by Accord Healthcare against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, INC.Nov 14, 2024
EP2493466Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA S.A.Aug 30, 2024
EP3744326Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICALS, INC.Aug 28, 2024
EP3263106Method For Suppressing Bitterness Of Quinoline DerivativeEISAI R&D MANAGEMENT CO., LTD.Jul 25, 2024
EP3883606Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 AntibodyJANSSEN BIOTECH, INC.Apr 12, 2024
EP2687202Subcutaneous Anti-Her2 Antibody FormulationF. HOFFMANN-LA ROCHE AGFeb 12, 2024
EP3324936Method For Producing A Bortezomib Ester SolutionSTADAJun 28, 2023
EP3324937Ready-To-Use Bortezomib SolutionSTADAMay 17, 2023
EP3524595High-Purity Quinoline Derivative And Method For Manufacturing SameEISAI R&D MANAGEMENT CO., LTD.May 10, 2023
EP2653873Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MA INC.Apr 18, 2023